Back to Report Store Home

Epilepsy Therapeutics in Asia-Pacific Markets to 2024 – Uptake of Novel Therapies and Rising Awareness is Expected to Drive the Market Growth

  • Published: Nov-2018
  • Report Code: GBIHC484MR
  • Report Format: pdf

Description

List of Figures

Figure 1: Epilepsy Therapeutics Market, Patient Distribution in APAC 10

Figure 2: Summary of the Pathophysiology of Seizures by Net Increased Neuronal Excitation 16

Figure 3: Algorithm for investigation of patient presenting with seizure 18

Figure 4: Algorithm for Choice of AED for New-Onset Epilepsy Patients 26

Figure 5: Treatment Algorithm for Status Epilepticus in Australia 27

Figure 6: Epilepsy Therapeutics Market, Comparative Efficacy and Safety Heatmap for Marketed Products 43

Figure 7: Pipeline for Epilepsy Therapeutics, Global, 2018 45

Figure 8: Pipeline for Epilepsy Therapeutics by Molecular Target, Global, 2018 47

Figure 9: Epilepsy Therapeutics Market, APAC, ZX008 Forecast ($m), 2020–2024 50

Figure 10: Epilepsy Therapeutics Market, APAC, Cenobamate Forecast ($m), 2020–2024 51

Figure 11: Epilepsy Therapeutics Market, Comparative Efficacy and Safety Heatmap for Pipeline Products 52

Figure 12: Epilepsy Therapeutics Market, Competitor Matrix for Epilepsy Marketed and Pipeline Products 53

Figure 13: Epilepsy Therapeutics, Global, Average Clinical Trial Failure Rate (%), 2007–2017 55

Figure 14: Epilepsy Therapeutics, Global, Clinical Trial Failure Rates by Molecular Target (%), 2007–2017 56

Figure 15: Epilepsy Therapeutics, Global, Clinical Trial Size per Product by Molecule Type (participants), 2007–2017 57

Figure 16: Epilepsy Therapeutics, Global, Clinical Trial Size per Product by Molecular Target (participants), 2007–2017 58

Figure 17: Epilepsy Therapeutics, Global, Clinical Trial Size per Trial by Molecule Type (participants), 2007–2017 59

Figure 18: Epilepsy Therapeutics, Global, Clinical Trial Size per Trial by Molecular Target (participants), 2007–2017 60

Figure 19: Epilepsy Therapeutics, Global, Clinical Trial Duration by Molecule Type (months), 2007–2017 61

Figure 20: Epilepsy Therapeutics, Global, Clinical Trial Duration by Molecular Target (months), 2007–2017 62

Figure 21: Epilepsy Therapeutics Market, Global, Comparison of Average Trial Metrics by Phase and Molecule Type 62

Figure 22: Epilepsy Therapeutics Market, Global, Comparison of Average Trial Metrics by Phase and Molecular Target 63

Figure 23: Epilepsy Therapeutics Market, Asia-Pacific, Treatment Patterns (million), 2017–2024 65

Figure 24: Epilepsy Therapeutics Market, APAC, Market Size ($m), 2017–2024 66

Figure 25: Epilepsy Therapeutics Market, India, Treatment Patterns (million), 2017–2024 67

Figure 26: Epilepsy Therapeutics Market, India, Annual Cost of Therapy ($), 2017–2024 69

Figure 27: Epilepsy Therapeutics Market, India, Market Size ($m), 2017–2024 70

Figure 28: Epilepsy Therapeutics Market, China, Treatment Patterns (million), 2017–2024 71

Figure 29: Epilepsy Therapeutics Market, China, Annual Cost of Therapy ($), 2017–2024 72

Figure 30: Epilepsy Therapeutics Market, China, Market Size ($m), 2017–2024 73

Figure 31: Epilepsy Therapeutics Market, Australia, Treatment Patterns (‘000), 2017–2024 74

Figure 32: Epilepsy Therapeutics Market, Australia, Annual Cost of Therapy ($), 2017–2024 75

Figure 33: Epilepsy Therapeutics Market, Australia, Market Size ($m), 2017–2024 76

Figure 34: Epilepsy Therapeutics Market, South Korea, Treatment Patterns (‘000), 2017–2024 77

Figure 35: Epilepsy Therapeutics Market, South Korea, Annual Cost of Therapy ($), 2017–2024 78

Figure 36: Epilepsy Therapeutics Market, South Korea, Market Size ($m), 2017–2024 79

Figure 37: Epilepsy Therapeutics Market, Japan, Treatment Patterns (000), 2017–2024 80

Figure 38: Epilepsy Therapeutics Market, Japan, Annual Cost of Therapy ($), 2017–2024 81

Figure 39: Epilepsy Therapeutics Market, Japan, Market Size ($m), 2017–2024 82

Figure 40: Epilepsy Therapeutics Market, Global, Licensing Deals By Region And Value, 2007–2018 86

Figure 41: Epilepsy Therapeutics Market, Global, Number of Disclosed and Undisclosed Licensing Deals by Year, Aggregate Deal Value and Aggregate Upfront Payment Value, 2007–2018 87

Figure 42: Epilepsy Therapeutics Market, Global, Licensing Deals by Stage of Development, Deal Value and Upfront Payment Value, 2007–2018 88

Figure 43: Epilepsy Therapeutics Market, Global, Licensing Deals by Molecule Type and Stage of Development, 2007–2018 89

Figure 44: Epilepsy Therapeutics Market, Global, Licensing Deals by Molecular Targets and Aggregate Deal Value ($), 2007–2018 90

Figure 45: Epilepsy Therapeutics Market, Global, Co-development Deals by Region and Deal Value, 2007–2018 92

Figure 46: Epilepsy Therapeutics Market, Global, Number of Disclosed and Undisclosed Co-development Deals by Year, Aggregate Deal Value and Aggregate Upfront Payment Value, 2008–2018 93

Figure 47: Epilepsy Therapeutics Market, Global, Co-development Deals by Stage of Development, Deal Value and Upfront Payment Value, 2007–2018 94

Figure 48: Epilepsy Therapeutics Market, Global, Co-development Deals by Molecule Type and Stage of Development, 2007–2018 95

Figure 49: Epilepsy Therapeutics Market, Global, Co-development Deals by Molecular Target, 2007–2018 95

 
      captcha refresh

I have read and accept terms and conditions and privacy policy

Cancel
License Details
Electronic PDF copy delivered via email. Report can be used by individual purchaser only.
Single User Licence
$4995
Electronic PDF copy delivered via email. Report can be shared by unlimited users within one corporate location, e.g. a regional office.
Site Licence
$9990
Electronic PDF copy delivered via email. Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company.
Global Licence
$14985
Email to a colleague Request Sample Pages Enquire Before Buying
Prefer to speak to a team member? Call us on:
+44 161 359 5414
Or click here to contact us
Secure Payments
Cards